Literature DB >> 2419411

Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21).

R Philip, A C Berger, N H McManus, N H Warner, M A Peacock, L B Epstein.   

Abstract

Peripheral blood leukocytes (PBL) from noninstitutionalized individuals with trisomy 21, paired with closely age-matched and/or family members as controls, were analyzed for different aspects of their cellular and humoral immune responses, and were phenotypically characterized by means of various monoclonal antibodies. Both the in vitro PBL proliferative and antibody responses to a bacterial antigen (tetanus toxoid) and to viral antigens (influenza A/Bangkok and B/Singapore) were significantly decreased in trisomy 21. In addition, bacterial and viral antigen-induced in vitro interleukin 2 (IL 2) production was markedly reduced, although mitogen (PHA)-stimulated IL 2 production was not impaired. The functional abnormalities observed in trisomy 21 PBL occur concomitantly with numerical alterations in circulating lymphocyte subsets in these same individuals. Although no difference was observed between the trisomic and control groups in the percentage of total T and B lymphocytes, a decreased level of Leu-3a + 3b-positive cells (T helper/inducer cells) and an increased level of Leu-2a-positive cells (T suppressor/cytotoxic cells) that co-expressed Leu-15 (suppressor alone) were noted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419411

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Differential expression of lymphocyte function-associated antigen (LFA-1) on peripheral blood leucocytes from individuals with Down's syndrome.

Authors:  M J Barrena; P Echaniz; C Garcia-Serrano; P Zubillaga; E Cuadrado
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

3.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  The expression of CD18 is increased on Trisomy 21 (Down syndrome) lymphoblastoid cells.

Authors:  G M Taylor; A Williams; S W D'Souza; W D Fergusson; D Donnai; J Fennell; R Harris
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

5.  T cell response to anti-CD3 antibody in Down's syndrome.

Authors:  A Bertotto; C Arcangeli; S Crupi; I Marinelli; R Gerli; R Vaccaro
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

6.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

Review 7.  Developmental genetics.

Authors:  C J Epstein
Journal:  Experientia       Date:  1986-10-15

8.  Increased CD11/CD18 expression on peripheral blood leucocytes of patients with sarcoidosis.

Authors:  Z Shakoor; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

Review 9.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

10.  Immune and TRG repertoire signature of the thymus in Down syndrome patients.

Authors:  Shira Rabinowicz; Atar Lev; Yu Nee Lee; Diti Machnes-Maayan; Uriel Katz; Amir Vardi; David Mishali; Raz Somech
Journal:  Pediatr Res       Date:  2020-03-31       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.